Follicular dendritic cell sarcoma in the setting of Castleman disease
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18097
Abstract: A 36yearold was referred to our centre following excision of a large retroperitoneal mass. This was found to primarily be hyalinevascular subtype Castleman disease (HVCD), but with two nodules of follicular dendritic cell sarcoma (FDCS).… read more here.
Keywords: cell sarcoma; disease; castleman disease; dendritic cell ... See more keywords
Next Generation Sequencing of Castleman Disease and Follicular Dendritic Cell Sarcomas Associated with Castleman Disease
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.4016.4016
Abstract: Castleman disease (CD) is a rare lymphoproliferative disorder, that can transform into malignant lymphomas during clinical progress. Histologically CD can be subdivided into a hyaline-vascular variant (CD-HVV), a plasma cell variant (CD-PCV) and an intermediate… read more here.
Keywords: medicine; fdcs; castleman disease; cell ... See more keywords
Availability and rationality of fixed dose combinations available in Kaduna, Nigeria
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacy Practice"
DOI: 10.18549/pharmpract.2019.2.1470
Abstract: Background: Fixed-dose drug combinations (FDCs), are combinations of two or more active drugs in a single dosage form. Despite the advantages obtained from the use of these agents, there is increasing evidence questioning the rationality… read more here.
Keywords: fdcs; fixed dose; kaduna nigeria; drug ... See more keywords